Skip to content

Management Migraine headache through medicated nasal drop

A clinical study to evaluate the efficacy of Nagarksheera Nasya in the management of Ardhavabhedaka w.s.r. to Migraine

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018113
Enrollment
40
Registered
2019-03-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G894- Chronic pain syndrome

Interventions

Intervention1: group A: Initially 4drops in each nostril are instilled. Then increased to 6, 8, 10 drops respectively and after that tapered. This is performed for 7 days, followed by a gap of 7 days.

Sponsors

Rishikul Campus
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulling the diagnostic criteria of migrainne and fit for Nasya Karma, indicated in text.

Exclusion criteria

Exclusion criteria: The patient having any complicated illnesss and pregnant & lactating females

Design outcomes

Primary

MeasureTime frame
To assess the effect of therapy objectilley, all the sgins and symptomms will be observed on the basis of percentile Marked improvement: 76-100% Moderate improvement : 51-75% Mild improvement: 26-50% No improvement: 0-25%Timepoint: Observation will be carried out at interval of 14 days for 42 days. Observation of patients will be carried out before, during and after completion of treatment.

Secondary

MeasureTime frame
Excerbation in signs and symptomsTimepoint: 1 month

Countries

India

Contacts

Public ContactDr K K Sharma

Rishikul Campus, U.A.U., Haridwar.

kripayanam@yahoo.com9758264164

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026